期刊文献+

^(13)C-美沙西汀呼气试验在肝病临床中的应用进展

下载PDF
导出
摘要 肝脏具有合成、代谢、排泄的功能。当各种原因引起肝脏功能受损时,其临床生化指标会发生变化。现有的生化检查的都是在体内有一定代谢周期的产物,反映的是患者1~2个月的肝细胞功能状况,并不能准确、全面地反映抽血取样当时的肝功能。1983年^13C-美沙西汀呼气试验在临床的运用,在一定程度上解决了以上问题,能够简单、即时、准确地反映检查当日的肝脏功能情况。
作者 瞿晴 吴云林
出处 《中国冶金工业医学杂志》 2006年第1期4-5,共2页 Chinese Medical Journal of Metallurgical industry
  • 相关文献

参考文献13

  • 1唐振铎 邱以永 夏宗勤 胡雅儿 黄腾昌 张乃立 鲁一红 李晶.^13C—美沙西汀呼气试验对肝病的诊断价值[J].中华内科杂志,1986,:722-724.
  • 2万荣,吴云林,王虹,瞿晴,张曙.^(13)C-美沙西丁呼气试验判断肝硬化患者肝功能[J].世界华人消化杂志,2004,12(9):2147-2149. 被引量:3
  • 3杨志忠,曾文炳.^13CO2呼气检查法S参数诊断肝脏疾病的研究[J].中华核医学杂志,1990,10(4):230-231. 被引量:1
  • 4Nista EC. ^13C-breath tests in the study of microsomal liver function. Eur Rev Med Pharmacol Sci,2004,8 : 33
  • 5Lara Baruque S. ^13C-phenylalanine and ^13C-methaeetin breath test to evaluate functional capacity of hepatoeyte in chronic liver disease. Dig Liver Dis, 2000 Apr; 32 : 226
  • 6Pfaffenbach B , The ^13 C-methacetin breath test for quantitative noninvasive liver function analysis with an isotope-specific nondispersive infrared spectrometer in liver cirrhosis. Dtsch Med Wochenschr, 1998; 123 : 1467
  • 7Klatt S. Evaluation of the ^13C-methacetin breath test for quantitative liver function testing. Z Gastrocntcrol, 1997; 35 : 609
  • 8Zipprich A. ^13C-Methacetin metabolism in patients with cirrhosis:relation to disease severity, haemoglobin content and oxygen supply. Aliment Pharmacol Ther, 2003; 17: 1559
  • 9Adamek RJ. ^13C-methacetin breath test: isotope-selective nondispersive infrared spectrometry in comparison to isotope ratio mass spectrometry in volunteers and patients with liver cirrhosis. Z Gastroenterol, 1999; 37:1139
  • 10Petrolati. ^13 C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther, 2004,19 : 243

二级参考文献42

  • 1曾文炳,中科院兰州地质所生物气体地球化学开放实验室研究年报,1986年
  • 2夏宗勤,核技术,1985年,3期,1页
  • 3邱以永,中华核医学杂志,1984年,4卷,129页
  • 4Ishii T, Furube M, Hirano S, Takatori K, Iida K, Kajiwara M.Evaluation of 13C-phenylalanine and 13C-tyrosine breath tests for the measurement of hepatocyte functional capacity in patients with liver cirrhosis. Chem Pharm Bull (Tokyo) 2001;49:1507-1511.
  • 5Kobayashi T, Kubota K, Imamura H, H-asegawa K, Inoue Y, Takayama T, Makuuchi M. Hepatic phenylalanine metabolism measured by the [^13C]phenylalanine breath test. Eur J Clin Invest 2001;31:356-361.
  • 6Saadeh S, Behrens PW, Parsi MA, Carey WD, Connor JT, Grealis M, Barnes DS. The utility of the ^13C-galactose breath test as a measure of liver function. Aliment Pharmacol Ther 2003;18:995-1002.
  • 7Park GJ, Katelaris PH, Jones DB, Seow F, Le Couteur DG, Ngu MC. Validity of the ^13C-caffeine breath test as a noninvasive, quantitative test of liver function. HepatoloRy 2003;38:1227-1236.
  • 8Ishii Y, Suzuki S, Kohno T, Aoki M, KohnoT, Ito A, Takayama T, Asai S. L-[1-^13C] phenylalanine breath test reflects histological changes in the liver. J Surg Res 2003;114:120-125.
  • 9Parra D, Gonzalez A, Garcia-Villarreal L, Martinez JA. Methodological characterization of the 2-keto [1-^13C]isocaproatebreath test to measure in vivo human mitochondrial function: application in alcoholic liver disease assessment. Alcohol Clin Exp Res 2003;27:1293-1298.
  • 10Ishii Y, Suzuki S, Kohno T, Aoki M, Kohno T, Ito A, Takayama T, Asai S. L-[1-13C] phenylalanine breath test reflects phenylalanine hydroxylase activity of the whole liver. J Surg Res 2003;112:38-42.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部